ImpediMed

About ImpediMed

ImpediMed is a company focused on medical bioimpedance spectroscopy (BIS) devices, dedicated to revolutionizing lymphedema care through early detection and management. Their mission is to empower patients, particularly those with breast cancer-related lymphedema, by providing innovative digital health solutions like the SOZO Digital Health Platform to improve patient outcomes across the care continuum.

Products & Services

SOZO® Digital Health Platform:An FDA-cleared bioimpedance spectroscopy solution for clinical assessment of lymphedema, offering systemwide, cloud-based early detection and management for breast cancer patients.

L-Dex® Analysis for Lymphedema:A tool for analyzing and detecting lymphedema, aiding in early intervention.

BodyComp™ Analysis:A solution for body composition analysis using bioimpedance technology.

Segmental BodyComp™ Analysis:Provides detailed segmental body composition analysis.

HF-Dex™ Analysis for Heart Failure:A bioimpedance-based analysis tool for assessing heart failure conditions.

Lymphedema Prevention Program (LPP):A program designed to detect lymphedema early in breast cancer patients to prevent progression to a chronic condition.

Research Devices (e.g., SFB7, ImpediVET):Specialized devices for research purposes in bioimpedance spectroscopy.

Specialties

Bioimpedance Spectroscopy (BIS) Lymphedema Detection and Prevention Breast Cancer-Related Lymphedema Heart Failure Analysis Rehabilitation and Therapy Body Composition Analysis

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 15000000 MR: - FA: $15 million FAN: 15000000	D: 2025-02-07 FD: 2025-02-07	1 investors

Debt Latest

2025-02-07

$15.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Parmjot Bains

Managing Director & CEO

M

McGregor Grant

Executive Director & CFO

S

Steven Chen

Chief Medical Officer

S

Scott Savage

Chief Product Officer

S

Scott Long

SVP, US Sales, Key Accounts, and Renewals

D

Dennis Schlaht

SVP R&D and Technology

View 12 more team members with Pro

Unlock Full Team Directory

Recent News

ImpediMed Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised